XM does not provide services to residents of the United States of America.

US stocks mixed as cyclicals take the lead, crude weakness persists



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>GLOBAL MARKETS-US stocks mixed as cyclicals take the lead, crude weakness persists</title></head><body>

Morgan Stanley beats estimates, stock touch record high

Grim ASML outlook hits chip stocks

Crude extends its slide

Updates to 10:52 EDT

By Stephen Culp

NEW YORK, Oct 16 (Reuters) -U.S. stocks were mixed on Wednesday and gold gained strength as bank earnings continued to beat expectations while fears of softening global demand weakenedmegacap growth stocks and quelledinvestor risk appetite.

The S&P 500's gains appeared to be held in check by underperforming megacap growth stocks, which pulled the Nasdaq into negative territory.

The blue-chip Dow, powered by financial shares, was modestly higher.

"Cyclicals and economically sensitive stocks have been outperforming," said Ross Mayfield, investment strategy analyst at Baird in Louisville, Kentucky. "I think the market believes a soft landing is being achieved and that the odds of reacceleration in growth are higher than the odds of recession.

Large banking firms have reported a string of upbeat earnings. Most recently, Morgan Stanley MS.N reported consensus-beating quarterly profit, sending its shares to a record high.

On Tuesday, chip equipment maker ASML ASML.AS forecast weaker than expected 2025 sales, prompting demand concerns.

"Bank results have been good, but the update from ASML <ASML.AS> and I think have led to a bit of a sell-off in AI (artificial intelligence)-adjacent space," Mayfield added.

The Dow Jones Industrial Average .DJI rose 197.71 points, or 0.46%, to 42,938.13. The S&P 500 .SPX climbed5.23 points, or 0.09%, to 5,820.35 and the Nasdaq Composite .IXIC fell 16.59 points, or 0.09%, to 18,299.00.

European stocks were modestly lower in the wake of disappointing results from ASMLand luxury goods maker LVMH<LVMH.PA> weighed on sentiment as investors remained cautious ahead of the European Central Bank's (ECB) policy decision on Thursday.

MSCI's gauge of stocks across the globe .MIWD00000PUS fell 0.98 points, or 0.12%, to 850.27.

The STOXX 600 .STOXX index fell 0.09%, while Europe's broad FTSEurofirst 300 index .FTEU3 fell 2.43 points, or 0.12%

Emerging market stocks .MSCIEF fell 5.88 points, or 0.51%, to 1,143.85.

Benchmark U.S. Treasury yields eased as financial markets cemented their bets for a smaller interest rate cut from the Federal Reserve at the conclusion of next month's policy meeting.

The yield on benchmark U.S. 10-year notes US10YT=RR fell 3 basis points to 4.008%, from 4.038% late on Tuesday.

The 30-year bond US30YT=RR yield fell 3.5 basis points to 4.2926% from 4.328% late on Tuesday.

The 2-year note US2YT=RR yield, which typically moves in step with interest rate expectations, fell 2.3 basis points to 3.933%, from 3.956% late on Tuesday.

The dollar posted a modest gain against a basket of world currencies as softer-than-expected British inflation data gave the Bank of England wiggle room to cut rates, sending the sterling lower, while the euro hit a 10-week low ahead of the ECB meeting.

The dollar index =USD, which measures the greenback against a basket of currencies including the yen and the euro, rose 0.14% to 103.40, with the euro EUR= down 0.09% at $1.088.

Against the Japanese yen JPY=, the dollar strengthened 0.27% to 149.59.

Oil prices dipped as expectations for ample supply offset simmering Middle East tensions, while OPEC and the International Energy Agency tempered their global demand forecasts for 2024 and 2025.

U.S. crude CLc1 fell 0.18% to $70.45 a barrel and Brent LCOc1 fell to $74.20 per barrel, down 0.05% on the day.

Gold prices extended recent gains, boosted by languid stocks and weaker bond yields.

Spot gold XAU= rose 0.4% to $2,671.75 an ounce.


World FX rates YTD http://tmsnrt.rs/2egbfVh

Asian stock markets https://tmsnrt.rs/2zpUAr4

European luxury and tech stocks struggle for momentum https://reut.rs/3zYybTU

Global assets YTD https://reut.rs/403fLfn


Reporting by Stephen Culp; Additional reporting by Amanda Cooper in London; Editing by Richard Chang

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.